RVTY

REVVITY INC

RVTY·714046109·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

RVTY (REVVITY INC) is held by 215 institutional investors as of Q2 2026. Largest holders: EdgePoint Investment Group Inc. ($950.7M), BlackRock, Inc. ($852.1M), VANGUARD CAPITAL MANAGEMENT LLC ($812.3M). Net institutional sentiment: Mixed. In Q2 2026, 3 members of Congress and 127 funds bought RVTY.

215
Holders
(17 Elite)
$8.7B
Total Value
58% (220)
Consensus
127 buying - 93 selling
13F: Insider & Congress: Updated regularly
RVTY

Smart Money Verdict

View all
Loading verdict
Held by 215 funds
17 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 25, 2026 · Activists Aug 14, 2026 · Congress Jun 8, 2026

InsiderMPMICHAS ALEXIS PGift 285 shAug 25, 2026
InsiderGSGoldberg Joel SGift 28K shAug 14, 2026
ActivistTRT. Rowe Price Investment Management, Inc.16.4%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
8.5M(-2.9%)$950.7M7.2%+23.79%
0
Increased
7.7M(+5.6%)$852.1M0.0%+15.15%
34
Decreased
7.3M(-0.4%)$812.3M0.0%+44.42%
0
Decreased
4.8M(-0.9%)$530.8M0.0%+44.42%
0
Increased
4.3M(+0.8%)$483.2M0.0%+16.37%
31
Increased
3.6M(+8.1%)$405.6M0.2%+40.25%
40
Increased
3.4M(+17.5%)$381.5M0.1%+17.97%
36
Increased
3M(+0.6%)$328.2M0.0%+14.96%
31
Decreased
2.6M(-4.0%)$286.5M0.0%+28.10%
0
Decreased
2.4M(-10.8%)$269.8M0.0%+12.96%
0
Decreased
2.2M(-1.4%)$251.4M0.4%+37.97%
0
Increased
1.9M(+35.2%)$208.7M0.1%+31.51%
47
Increased
1.9M(+37.5%)$207.4M0.0%+23.07%
40
Increased
1.6M(+81.8%)$181.5M0.2%+17.13%
56
Increased
1.5M(+2226.0%)$162.1M0.0%+14.33%
49
Increased
1.1M(+0.0%)$120.8M0.0%+25.62%
30
Increased
1.1M(+134.2%)$120.2M1.1%+25.01%
77
Increased
944,563(+1.7%)$105.1M0.0%+15.47%
30
Increased
900,351(+87.1%)$100.2M0.0%+18.32%
47
Increased
865,575(+107x)$96.3M0.0%+13.69%
48

Showing 1-20 of 226

1 / 12
RVTYRVTYREVVITY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used